1) Formocortal
福莫可他
2) Tacrolimus
他可莫司
1.
Analyzing of the results of whole blood concentrations of tacrolimus by microparticle enzyme immuno assay;
微粒子酶免分析法测定他可莫司全血浓度结果分析
2.
Objective To investigate the effects of tacrolimus in nephrotoxic serum nephritis in rats by detecting the expressions of a-SMA and Bcl-2 in the kidney tissue.
目的 探讨大鼠肾毒血清性肾炎模型发病过程中肾组织内α-SMA和Bcl-2表达特点及他克莫司对其表达的影响，探讨他可莫司对肾毒血清性肾小球肾炎的干预治疗作用。
3) FK506
他可莫司
1.
[Objective] To investigate bcl-2,bcl-2-mRNA expression in renal preservation and effect of FK506.
目的探讨离体肾脏保存过程中bcl-2蛋白、bcl-2 mRNA表达及他可莫司(FK 506)对其的影响。
4) Tacrolimus/FK506
FK506/他可莫司
5) formoterol
福莫特罗
1.
Efficacy of formoterol in asthma: a multicenter, double-blind and randomized study;
福莫特罗治疗支气管哮喘的多中心临床研究
2.
Comparison of the efficacy and safety of inhaled formoterol versus inhaled salbutamol in treatment of adult bronchial asthma;
吸入福莫特罗与沙丁胺醇治疗支气管哮喘的疗效和安全性比较
3.
Comparison of bronchodilating and antiinflammatory activities of oral formoterol and its (R,R)-enantiomers;
口服福莫特罗与其(R,R)对映体的支气管扩张和抗炎活性比较(英文)
6) fotemustine
福莫司汀
1.
Efficacy evaluation of fotemustine administered in adult patients with supratentorial malignant glioma;
福莫司汀治疗成人幕上恶性胶质瘤疗效观察
2.
Effect of fotemustine on the cell cycle of human glioma cell line U251;
福莫司汀对人脑胶质瘤细胞株U251细胞周期的影响
3.
Objective:To prepare polybutylcyanoacrylate(PBCA) nanocarriers with optimized process,double-located with Tween80 and(or) polyethylene glycol(PEG)20000,to further prepare fotemustine polybutylcyanoacrylate nanoparticles(FCNU-PBCA-NP) and temozolomide polybutylcyanoacrylate nanoparticles(TMZ-PBCA-NP).
目的:优化工艺制备吐温80和(或)PEG20000双重修饰的聚氰基丙烯酸正丁酯纳米载体,进一步制备包载福莫司汀、替莫唑胺的聚氰基丙烯酸正丁酯纳米粒。
补充资料：阿西莫司
分子式：C6H6N2O3
分子量：暂无
CAS号：51037-30-0
性质：暂无
制备方法：暂无
用途：降血脂药。
分子量：暂无
CAS号：51037-30-0
性质：暂无
制备方法：暂无
用途：降血脂药。
说明：补充资料仅用于学习参考，请勿用于其它任何用途。
参考词条